Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Oncogenic drivers such as KRAS extensively modulate the tumor inflammatory microenvironment (TIME) of colorectal cancer (CRC). The influence of KRAS on modulating immune cell composition remains unclear. The objective of this study was to identify signatures of infiltrative immune cells and distinct...
Saved in:
| Main Authors: | Emil Lou, Joanne Xiu, Yasmine Baca, Anwaar Saeed, Ajay Prakash, Sepideh Gholami, Subbaya Subramanian, Timothy K. Starr, Elisa Fontana, Ritu Pandey, Heinz-Josef Lenz, Anthony F. Shields, Chadi Nabhan, Matthew Oberley, Andreas Seeber, Wafik El-Deiry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Molecular Therapy: Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329924000286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The complex journey of targeting RAS in oncology
by: Katarzyna Wasiak, et al.
Published: (2025-07-01) -
Efek Mutasi K-RAS pada Kanker Kolorektal terhadap Terapi Antibodi Monoklonal anti EGFR
by: Farid Sastra Nagara, et al.
Published: (2008-12-01) -
Examining the Outcomes of Palliative Oophorectomy of Ovarian Metastases in de-Novo Metastatic Colorectal Cancer and Its Association with RAS Mutation Status: Insights from a Single-Institution Perspective
by: Alawabdeh T, et al.
Published: (2025-03-01) -
Association Between CD147 Expression, RAS Mutational Status, and Local Recurrence in Resected Locally Advanced Rectal Cancer
by: Anaëlle Isnard, et al.
Published: (2025-08-01) -
Elevated KRAS protein level is associated with better survival in pancreatic cancer
by: S. M. Stålberg, et al.
Published: (2025-07-01)